Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

The Clinical Impact of Psoas Muscle Cross-Sectional Area on Medium-Term Mortality After Transcatheter Aortic Valve Implantation.

Michel J, Pellegrini C, Rheude T, von Scheid M, Trenkwalder T, Elhmidi Y, Mayr NP, Brecker S, Kasel AM, Kastrati A, Schunkert H, Husser O, Bleiziffer S, Hengstenberg C.

Heart Lung Circ. 2019 May 23. pii: S1443-9506(19)30474-3. doi: 10.1016/j.hlc.2019.05.095. [Epub ahead of print]

PMID:
31182269
2.

One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3.

Pellegrini C, Rheude T, Trenkwalder T, Mayr NP, Joner M, Kastrati A, Schunkert H, Husser O, Hengstenberg C.

Clin Res Cardiol. 2019 May 2. doi: 10.1007/s00392-019-01461-7. [Epub ahead of print]

PMID:
31049679
3.

Neuroimaging and Stereotactic Body Radiation Therapy (SBRT) for Spine Metastasis.

Khan M, Garg R, Gui C, Lee Y, Sahgal A, Mossa-Basha M, Mayr N, Lo S, Redmond K.

Top Magn Reson Imaging. 2019 Apr;28(2):85-96. doi: 10.1097/RMR.0000000000000199.

PMID:
31022051
4.

What Neuroradiologists Need to Know About Radiation Treatment for Neural Tumors.

Oztek MA, Tseng YD, Mayr NA, Parvathaneni U.

Top Magn Reson Imaging. 2019 Apr;28(2):37-47. doi: 10.1097/RMR.0000000000000196.

PMID:
31022047
5.

Advanced Neuroimaging for Advanced Radiation Therapy.

Mayr NA, Lo SS, Oztek MA, Colip CG, Yuh WTC.

Top Magn Reson Imaging. 2019 Apr;28(2):35-36. doi: 10.1097/RMR.0000000000000200. No abstract available.

PMID:
31022046
6.

CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy.

Peeken JC, Bernhofer M, Spraker MB, Pfeiffer D, Devecka M, Thamer A, Shouman MA, Ott A, Nüsslin F, Mayr NA, Rost B, Nyflot MJ, Combs SE.

Radiother Oncol. 2019 Jun;135:187-196. doi: 10.1016/j.radonc.2019.01.004. Epub 2019 Apr 5.

PMID:
30961895
7.

One-year clinical outcome with a novel self-expanding transcatheter heart valve.

Pellegrini C, Rheude T, Trenkwalder T, Mayr NP, Michel J, Kastrati A, Schunkert H, Kasel AM, Joner M, Hengstenberg C, Husser O.

Catheter Cardiovasc Interv. 2019 Feb 24. doi: 10.1002/ccd.28144. [Epub ahead of print]

PMID:
30801906
8.

Assessing the level of radiation experienced by anesthesiologists during transfemoral Transcatheter Aortic Valve Implantation and protection by a lead cap.

Mayr NP, Wiesner G, Kretschmer A, Brönner J, Hoedlmoser H, Husser O, Kasel AM, Lange R, Tassani-Prell P.

PLoS One. 2019 Jan 30;14(1):e0210872. doi: 10.1371/journal.pone.0210872. eCollection 2019.

9.

Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Núñez J, Joner M, Trenkwalder T, Mayr NP, Holdenrieder S, Bodi V, Koenig W, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Rev Esp Cardiol (Engl Ed). 2018 Oct 25. pii: S1885-5857(18)30390-6. doi: 10.1016/j.rec.2018.09.006. [Epub ahead of print] English, Spanish.

PMID:
30482731
10.

Critical adverse events during transfemoral TAVR in conscious sedation. Is an anesthesiologic support mandatory?

Mayr NP, Wiesner G, Husser O, Joner M, Michel J, Knorr J, Pellegrini C, Bleiziffer S, Schunkert H, Lange R, Tassani-Prell P.

Cardiovasc Revasc Med. 2018 Sep;19(6S):41-46. doi: 10.1016/j.carrev.2018.06.014. Epub 2018 Jun 21.

PMID:
30327095
11.

Prophylactic ECMO during TAVI in patients with depressed left ventricular ejection fraction.

Trenkwalder T, Pellegrini C, Holzamer A, Rheude T, Riester J, Reinhard W, Mayr NP, Kasel AM, Gaede L, Blumenstein J, Kastrati A, Schunkert H, Joner M, Hilker M, Hengstenberg C, Husser O.

Clin Res Cardiol. 2019 Apr;108(4):366-374. doi: 10.1007/s00392-018-1364-6. Epub 2018 Aug 28.

PMID:
30155732
12.

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies.

Schaub SK, Hartvigson PE, Lock MI, Høyer M, Brunner TB, Cardenes HR, Dawson LA, Kim EY, Mayr NA, Lo SS, Apisarnthanarax S.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818790217. doi: 10.1177/1533033818790217. Review.

13.

Multicenter Evaluation of Prosthesis Oversizing of the SAPIEN 3 Transcatheter Heart Valve. Impact on Device Failure and New Pacemaker Implantations.

Pellegrini C, Kim WK, Holzamer A, Walther T, Mayr NP, Michel J, Rheude T, Nuñez J, Kasel AM, Trenkwalder T, Kaess BM, Joner M, Kastrati A, Schunkert H, Hilker M, Möllmann H, Hengstenberg C, Husser O.

Rev Esp Cardiol (Engl Ed). 2018 Jul 14. pii: S1885-5857(18)30239-1. doi: 10.1016/j.rec.2018.06.005. [Epub ahead of print] English, Spanish.

PMID:
30017841
14.

The evolution and rise of stereotactic body radiotherapy (SBRT) for spinal metastases.

Vellayappan BA, Chao ST, Foote M, Guckenberger M, Redmond KJ, Chang EL, Mayr NA, Sahgal A, Lo SS.

Expert Rev Anticancer Ther. 2018 Sep;18(9):887-900. doi: 10.1080/14737140.2018.1493381. Epub 2018 Jul 3. Review.

PMID:
29940802
15.

A ring-based compensator IMRT system optimized for low- and middle-income countries: Design and treatment planning study.

Van Schelt J, Smith DL, Fong N, Toomeh D, Sponseller PA, Brown DW, Macomber MW, Mayr NA, Patel S, Shulman A, Subrahmanyam GV, Govindarajan KN, Ford EC.

Med Phys. 2018 Jul;45(7):3275-3286. doi: 10.1002/mp.12985. Epub 2018 Jun 10.

PMID:
29777595
16.

Effects of Preparatory Coaching and Home Practice for Deep Inspiration Breath Hold on Cardiac Dose for Left Breast Radiation Therapy.

Kim A, Kalet AM, Cao N, Hippe DS, Fang LC, Young L, Meyer J, Lang EV, Mayr NA.

Clin Oncol (R Coll Radiol). 2018 Sep;30(9):571-577. doi: 10.1016/j.clon.2018.04.009.

PMID:
29773446
17.

Predictors of Need for Permanent Pacemaker Implantation and Conduction Abnormalities With a Novel Self-expanding Transcatheter Heart Valve.

Pellegrini C, Husser O, Kim WK, Holzamer A, Walther T, Rheude T, Mayr NP, Trenkwalder T, Joner M, Michel J, Chaustre F, Kastrati A, Schunkert H, Burgdorf C, Hilker M, Möllmann H, Hengstenberg C.

Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):145-153. doi: 10.1016/j.rec.2018.01.011. Epub 2018 Mar 16. English, Spanish.

PMID:
29551701
18.

Incidental findings in multislice computed tomography prior to transcatheter aortic valve implantation: frequency, clinical relevance and outcome.

Trenkwalder T, Lahmann AL, Nowicka M, Pellegrini C, Rheude T, Mayr NP, Voss S, Bleiziffer S, Lange R, Joner M, Kasel AM, Kastrati A, Schunkert H, Husser O, Hadamitzky M, Hengstenberg C.

Int J Cardiovasc Imaging. 2018 Jun;34(6):985-992. doi: 10.1007/s10554-018-1305-5. Epub 2018 Feb 21.

PMID:
29468355
19.

Dexmedetomidine versus propofol-opioid for sedation in transcatheter aortic valve implantation patients: a retrospective analysis of periprocedural gas exchange and hemodynamic support.

Mayr NP, Wiesner G, van der Starre P, Hapfelmeier A, Goppel G, Kasel AM, Hengstenberg C, Husser O, Schunkert H, Tassani-Prell P.

Can J Anaesth. 2018 Jun;65(6):647-657. doi: 10.1007/s12630-018-1092-4. Epub 2018 Feb 20.

PMID:
29464420
20.

Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Schmid H, Trenkwalder T, Mayr NP, Joner M, Kasel AM, Holdenrieder S, Nunez J, Sanchis J, Bodi V, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Am J Cardiol. 2018 Feb 15;121(4):461-468. doi: 10.1016/j.amjcard.2017.11.020. Epub 2017 Nov 27.

PMID:
29306485
21.

Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.

Rheude T, Pellegrini C, Reinhard W, Trenkwalder T, Koenig W, Mayr NP, Joner M, Núñez J, Holdenrieder S, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Biomarkers. 2018 May;23(3):299-304. doi: 10.1080/1354750X.2018.1423706. Epub 2018 Jan 15.

PMID:
29297708
22.

Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015.

Trenkwalder T, Pellegrini C, Holzamer A, Philipp A, Rheude T, Michel J, Reinhard W, Joner M, Kasel AM, Kastrati A, Schunkert H, Endemann D, Debl K, Mayr NP, Hilker M, Hengstenberg C, Husser O.

Catheter Cardiovasc Interv. 2018 Jul;92(1):149-156. doi: 10.1002/ccd.27385. Epub 2017 Nov 11.

PMID:
29130616
23.

Periprocedural transfusion in patients undergoing transfemoral transcatheter aortic valve implantation.

Mayr NP, Wiesner G, Hapfelmeier A, van der Starre P, Husser O, Bleiziffer S, Schunkert H, Lange R, Tassani-Prell P, Martin K.

Catheter Cardiovasc Interv. 2018 Jul;92(1):141-148. doi: 10.1002/ccd.27382. Epub 2017 Nov 11.

PMID:
29130582
24.

Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.

Bowen SR, Yuh WTC, Hippe DS, Wu W, Partridge SC, Elias S, Jia G, Huang Z, Sandison GA, Nelson D, Knopp MV, Lo SS, Kinahan PE, Mayr NA.

J Magn Reson Imaging. 2018 May;47(5):1388-1396. doi: 10.1002/jmri.25874. Epub 2017 Oct 16.

25.

Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation.

Rheude T, Pellegrini C, Michel J, Trenkwalder T, Mayr NP, Kessler T, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Int J Cardiol. 2017 Oct 1;244:93-99. doi: 10.1016/j.ijcard.2017.06.024. Epub 2017 Jun 13.

PMID:
28645804
26.

Strategies to tackle the challenges of external beam radiotherapy for liver tumors.

Lock MI, Klein J, Chung HT, Herman JM, Kim EY, Small W, Mayr NA, Lo SS.

World J Hepatol. 2017 May 18;9(14):645-656. doi: 10.4254/wjh.v9.i14.645. Review.

27.

Bridging Innovation and Outreach to Overcome Global Gaps in Radiation Oncology Through Information and Communication Tools, Trainee Advancement, Engaging Industry, Attention to Ethical Challenges, and Political Advocacy.

Dad L, Royce TJ, Morris Z, Moran M, Pawlicki T, Khuntia D, Hardenbergh P, Cummings B, Mayr N, Hu K.

Semin Radiat Oncol. 2017 Apr;27(2):98-108. doi: 10.1016/j.semradonc.2016.11.002. Epub 2016 Nov 9. Review.

PMID:
28325248
28.

Intravoxel incoherent motion MRI assessment of chemoradiation-induced pelvic bone marrow changes in cervical cancer and correlation with hematological toxicity.

Lee EYP, Perucho JAU, Vardhanabhuti V, He J, Siu SWK, Ngu SF, Mayr NA, Yuh WTC, Chan Q, Khong PL.

J Magn Reson Imaging. 2017 Nov;46(5):1491-1498. doi: 10.1002/jmri.25680. Epub 2017 Feb 22.

PMID:
28225579
29.

An image-guided precision proton radiation platform for preclinical in vivo research.

Ford E, Emery R, Huff D, Narayanan M, Schwartz J, Cao N, Meyer J, Rengan R, Zeng J, Sandison G, Laramore G, Mayr N.

Phys Med Biol. 2017 Jan 7;62(1):43-58. Epub 2016 Dec 14.

PMID:
27973343
30.

Comment to: De Waha S, Seeburger J et al. (2016): Deep sedation versus general anaesthesia in percutaneous edge-to edge mitral valve reconstruction using the MitraClip system. Clin Res Cardiol 105(6):535-43.

Wiesner G, Tassani-Prell P, Mayr NP.

Clin Res Cardiol. 2017 Feb;106(2):160-161. doi: 10.1007/s00392-016-1046-1. Epub 2016 Nov 4. No abstract available.

PMID:
27815637
31.

Computed tomography imaging assessment of postexternal beam radiation changes of the liver.

Lock M, Malayeri AA, Mian OY, Mayr NA, Herman JM, Lo SS.

Future Oncol. 2016 Dec;12(23):2729-2739. Epub 2016 Aug 31. Review.

32.

Effect of team training on improving MRI study completion rates and no-show rates.

Norbash A, Yucel K, Yuh W, Doros G, Ajam A, Lang E, Pauker S, Mayr N.

J Magn Reson Imaging. 2016 Oct;44(4):1040-7. doi: 10.1002/jmri.25219. Epub 2016 Apr 6.

33.

Assessment of vitamin D status and serum CrossLaps levels in adults with primary lactose malabsorption.

Enko D, Kriegshäuser G, Stolba R, Mangge H, Brandstetter D, Mayr N, Forstner T, Halwachs-Baumann G.

Eur J Clin Nutr. 2016 Sep;70(9):1000-3. doi: 10.1038/ejcn.2016.66. Epub 2016 Apr 27.

PMID:
27117931
34.

Technical know-how in stereotactic ablative radiotherapy (SABR).

Lo SS, Foote M, Siva S, Slotman BJ, Teh BS, Guckenberger M, Tan D, Mayr NA, Sahgal A.

J Med Radiat Sci. 2016 Mar;63(1):5-8. doi: 10.1002/jmrs.163. Epub 2016 Mar 3.

35.

Inter-Fraction Tumor Volume Response during Lung Stereotactic Body Radiation Therapy Correlated to Patient Variables.

Salamekh S, Rong Y, Ayan AS, Mo X, Williams TM, Mayr NA, Grecula JC, Chakravarti A, Xu-Welliver M.

PLoS One. 2016 Apr 6;11(4):e0153245. doi: 10.1371/journal.pone.0153245. eCollection 2016.

36.

Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions.

Myrehaug S, Sahgal A, Russo SM, Lo SS, Rosati LM, Mayr NA, Lock M, Small W Jr, Dorth JA, Ellis RJ, Teh BS, Herman JM.

Expert Rev Anticancer Ther. 2016 May;16(5):523-30. doi: 10.1586/14737140.2016.1168698. Epub 2016 Apr 18. Review.

PMID:
26999329
37.

Closing the Cancer Divide Through Ubuntu: Information and Communication Technology-Powered Models for Global Radiation Oncology.

Ngwa W, Ngoma T, Zietman A, Mayr N, Elzawawy A, Winningham TA, Balogun O, Enwerem-Bromson N, Ntizimira C, Olopade OI, Oluwole D, Odedina F, Williams M, Flanigan J, Asana L, Ngwa K, Avery S, Pollard JM, Roland T, Funwi-gabga N, Mbarika V, Hardenbergh P, Winkfield K, Pipman Y, Stefan C, Ngoma M, Mohammed S, Katz M, Erno S, Moni J, Fitzgerald T, Tonlaar N, Efstathiou J, Gierga D, Ayo C, Knaul F, Gospodarowicz M, Makrigiorgos GM, Nguyen PL.

Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):440-9. doi: 10.1016/j.ijrobp.2015.10.063. Epub 2015 Nov 6. No abstract available.

38.

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve.

Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, Kasel AM, Kastrati A, Schunkert H, Hengstenberg C.

JACC Cardiovasc Interv. 2016 Feb 8;9(3):244-254. doi: 10.1016/j.jcin.2015.09.036.

39.

Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.

Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, Ott I, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C.

JACC Cardiovasc Interv. 2015 Dec 21;8(14):1809-16. doi: 10.1016/j.jcin.2015.08.014.

40.

Sedation or general anesthesia for transcatheter aortic valve implantation (TAVI).

Mayr NP, Michel J, Bleiziffer S, Tassani P, Martin K.

J Thorac Dis. 2015 Sep;7(9):1518-26. doi: 10.3978/j.issn.2072-1439.2015.08.21. Review.

41.

Comparison of sedation and general anaesthesia for transcatheter aortic valve implantation on cerebral oxygen saturation and neurocognitive outcome†.

Mayr NP, Hapfelmeier A, Martin K, Kurz A, van der Starre P, Babik B, Mazzitelli D, Lange R, Wiesner G, Tassani-Prell P.

Br J Anaesth. 2016 Jan;116(1):90-9. doi: 10.1093/bja/aev294. Epub 2015 Sep 29.

42.

The development of stereotactic body radiotherapy in the past decade: a global perspective.

Lo SS, Slotman BJ, Lock M, Nagata Y, Guckenberger M, Siva S, Foote M, Tan D, Teh BS, Mayr NA, Chang EL, Timmerman RD, Sahgal A.

Future Oncol. 2015 Oct;11(19):2721-2733. doi: 10.2217/fon.15.220. Epub 2015 Sep 4.

PMID:
26338676
43.

Strangulating Closed-Loop Obstruction: Sonographic Signs.

Hollerweger A, Rieger S, Mayr N, Mittermair C, Schaffler G.

Ultraschall Med. 2016 Jun;37(3):271-6. doi: 10.1055/s-0034-1398988. Epub 2015 Apr 15.

PMID:
25876222
44.

Structural valve deterioration 4 years after transcatheter aortic valve replacement: imaging and pathohistological findings.

Deutsch MA, Mayr NP, Assmann G, Will A, Krane M, Piazza N, Bleiziffer S, Lange R.

Circulation. 2015 Feb 17;131(7):682-5. doi: 10.1161/CIRCULATIONAHA.114.013995. No abstract available.

PMID:
25691705
45.

Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma.

Klein J, Korol R, Lo SS, Chu W, Lock M, Dorth JA, Ellis RJ, Mayr NA, Huang Z, Chung HT.

Future Oncol. 2014 Nov;10(14):2227-41. doi: 10.2217/fon.14.167. Review.

PMID:
25471036
46.

Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer.

Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):320-8. doi: 10.1016/j.ijrobp.2014.06.005.

47.

Combination of stereotactic ablative body radiation with targeted therapies.

Zeng J, Baik C, Bhatia S, Mayr N, Rengan R.

Lancet Oncol. 2014 Sep;15(10):e426-34. doi: 10.1016/S1470-2045(14)70026-9. Review.

PMID:
25186046
48.

Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome prediction.

Huang Z, Yuh KA, Lo SS, Grecula JC, Sammet S, Sammet CL, Jia G, Knopp MV, Wu Q, Beauchamp NJ 3rd, Yuh WT, Wang R, Mayr NA.

Magn Reson Imaging. 2014 Dec;32(10):1198-205. doi: 10.1016/j.mri.2014.08.039. Epub 2014 Aug 29.

49.

Stereotactic ablative therapy and the central chest: in regard to Oskan.

Lo SS, Huang Z, Yuh WT, Mayr NA.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1143. doi: 10.1016/j.ijrobp.2014.04.035. Epub 2014 Jul 8. No abstract available.

PMID:
25035225
50.

Imaging across the life span: innovations in imaging and therapy for gynecologic cancer.

Xu-Welliver M, Yuh WT, Fielding JR, Macura KJ, Huang Z, Ayan AS, Backes FJ, Jia G, Moshiri M, Zhang J, Mayr NA.

Radiographics. 2014 Jul-Aug;34(4):1062-81. doi: 10.1148/rg.344130099.

Supplemental Content

Support Center